BG105624A - Process for preparing n6-substituted deaza-adenosine derivatives - Google Patents

Process for preparing n6-substituted deaza-adenosine derivatives

Info

Publication number
BG105624A
BG105624A BG105624A BG10562401A BG105624A BG 105624 A BG105624 A BG 105624A BG 105624 A BG105624 A BG 105624A BG 10562401 A BG10562401 A BG 10562401A BG 105624 A BG105624 A BG 105624A
Authority
BG
Bulgaria
Prior art keywords
preparing
adenosine derivatives
substituted
deaza
substituted deaza
Prior art date
Application number
BG105624A
Other languages
Bulgarian (bg)
English (en)
Inventor
Richard SALAZAR
Walter Rodriguez
James SHERBINE
Rick WOODWARD
Adam SLEDESKI
Matthew Powers
Michael O'brien
Original Assignee
Aventis Pharmaceuticals Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Products Inc. filed Critical Aventis Pharmaceuticals Products Inc.
Publication of BG105624A publication Critical patent/BG105624A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG105624A 1998-12-21 2001-06-20 Process for preparing n6-substituted deaza-adenosine derivatives BG105624A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21
PCT/US1999/029643 WO2000037469A2 (en) 1998-12-21 1999-12-14 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (1)

Publication Number Publication Date
BG105624A true BG105624A (en) 2002-01-31

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105624A BG105624A (en) 1998-12-21 2001-06-20 Process for preparing n6-substituted deaza-adenosine derivatives

Country Status (28)

Country Link
US (1) US6184382B1 (xx)
EP (1) EP1175420B1 (xx)
JP (1) JP2002533343A (xx)
KR (1) KR20010087425A (xx)
CN (1) CN1122667C (xx)
AP (1) AP1336A (xx)
AT (1) ATE235493T1 (xx)
AU (1) AU774155B2 (xx)
BG (1) BG105624A (xx)
BR (1) BR9917088A (xx)
CA (1) CA2357760A1 (xx)
CZ (1) CZ20012283A3 (xx)
DE (1) DE69906392T2 (xx)
DK (1) DK1175420T3 (xx)
EA (1) EA003645B1 (xx)
EE (1) EE200100333A (xx)
ES (1) ES2191489T3 (xx)
HK (1) HK1041607A1 (xx)
HU (1) HUP0105224A3 (xx)
ID (1) ID30118A (xx)
IL (1) IL143843A0 (xx)
NO (1) NO319789B1 (xx)
NZ (1) NZ512500A (xx)
PL (1) PL349154A1 (xx)
PT (1) PT1175420E (xx)
SK (1) SK284767B6 (xx)
WO (1) WO2000037469A2 (xx)
YU (1) YU51401A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713705A (pt) * 1996-12-11 2000-05-09 Rhone Poulenc Rorer Pharma Composto, e, processo para a preparação do mesmo
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
WO1992005177A1 (en) * 1990-09-25 1992-04-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties

Also Published As

Publication number Publication date
AP1336A (en) 2004-11-30
SK9072001A3 (en) 2001-12-03
IL143843A0 (en) 2002-04-21
WO2000037469A2 (en) 2000-06-29
AU774155B2 (en) 2004-06-17
NO20013044L (no) 2001-08-20
DE69906392D1 (de) 2003-04-30
HUP0105224A3 (en) 2003-01-28
CA2357760A1 (en) 2000-06-29
ATE235493T1 (de) 2003-04-15
PT1175420E (pt) 2003-08-29
EE200100333A (et) 2002-08-15
AP2001002200A0 (en) 2001-09-30
SK284767B6 (sk) 2005-11-03
DK1175420T3 (da) 2003-07-07
EA200100697A1 (ru) 2001-12-24
NO319789B1 (no) 2005-09-12
HK1041607A1 (zh) 2002-07-12
CZ20012283A3 (cs) 2001-10-17
EP1175420A2 (en) 2002-01-30
ES2191489T3 (es) 2003-09-01
NO20013044D0 (no) 2001-06-19
WO2000037469B1 (en) 2000-11-02
PL349154A1 (en) 2002-07-01
CN1122667C (zh) 2003-10-01
ID30118A (id) 2001-11-08
NZ512500A (en) 2003-01-31
DE69906392T2 (de) 2004-02-05
EA003645B1 (ru) 2003-08-28
CN1333773A (zh) 2002-01-30
BR9917088A (pt) 2006-01-31
HUP0105224A2 (en) 2002-06-29
AU2181400A (en) 2000-07-12
US6184382B1 (en) 2001-02-06
KR20010087425A (ko) 2001-09-15
WO2000037469A3 (en) 2000-09-14
YU51401A (sh) 2003-12-31
JP2002533343A (ja) 2002-10-08
EP1175420B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
AU2489197A (en) Carbocyclic intermediates and process of manufacture thereof
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
BG101833A (en) Guanine derivative
BG105028A (en) Bridged indenopyrrolocarbazoles
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
NO971645L (no) Fremgangsmåte for fremstilling av derivater av 4a,5,9,10,11,12,-heksahydro-6H-benzofuro£3a,3,2-ef|£2|-benzacepin
UA6044A1 (uk) Спосіб одержання метіленових похідних андроста-1,4 -діен-3,17-діона
HK1040239A1 (en) Process for preparing N6-substituted deaza-adenosine derivatives.
JO2252B1 (en) Method for preparing pyridine derivatives
ZA974952B (en) 2'-substituted nucleosides and oligonucleotide derivatives.
HK1034512A1 (en) Process for the production of purine derivatives and intermediates therefor
MY116766A (en) Improved process for antiparasitic agent
SI1102765T1 (en) PROCESS FOR THE SYNTHESIS OF (1$i(H))-BENZO C)QUINOLIZIN-3-ONES DERIVATIVES
BG105624A (en) Process for preparing n6-substituted deaza-adenosine derivatives
BG106002A (en) Process for preparing pesticidal intermediates
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
ZA200005110B (en) Process for preparing intermediates.
IL121352A0 (en) Intermediates for the preparation of 2-imidazolin-5-ones
UA81595C2 (xx) Спосіб очищення карбоксальдегіду$способ очищения карбоксальдегида
TWI265923B (en) Process for the preparation of 3-acylated indoles
HK1009451A1 (en) Process for the synthesis of nucleoside analogues
HUP0102297A2 (hu) Eljárás 4,5-epoxi-morfinán-6-oxi-glükuronidok előállítására
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
MY127539A (en) Bridged indenopyrrolocarbazoles